Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K on October 22, 2013, to report its financial results for the third quarter ended September 30, 2013. This report primarily serves to furnish a press release detailing these results, which is attached as Exhibit 99.1. Investors should note that the information provided in this filing is furnished under Item 2.02 and is not considered 'filed' for purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities. The core purpose of this filing is to make the market aware of IDEXX's quarterly performance. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release for comprehensive information on the company's financial condition and results of operations for the period. Investors seeking to understand IDEXX's performance in Q3 2013 would need to review the referenced press release.
Key Highlights
- 1IDEXX Laboratories filed an 8-K on October 22, 2013, to announce its third quarter financial results.
- 2The filing is primarily a notification and includes a press release with the detailed financial results as an exhibit.
- 3The press release (Exhibit 99.1) contains the company's results of operations and financial condition for the quarter ended September 30, 2013.
- 4Information furnished under Item 2.02 is not considered 'filed' for legal liability purposes under Section 18 of the Exchange Act.
- 5The filing is a standard procedure to inform investors and the market about quarterly financial performance.
- 6Key financial metrics and operational details would be found within the attached press release, not the 8-K form itself.